活血化瘀法治疗盆腔炎性疾病后遗症的临床用药研究  

Clinical medication and network pharmacology research on the treatment of pelvic inflammatory disease sequelae using the method of promoting blood circulation and resolving stasis

作　　者：李杨[1,2] 董书含 刘丽[2] LI Yang;DONG Shuhan;LIU Li(Heilongjiang University of Chinese Medicine Graduate Academy,Harbin Heilongjiang 150040,China;The First Affiliated Hospital of Heilongjiang University of Chinese Medicine,Harbin Heilongjiang 150040,China)

机构地区：[1]黑龙江中医药大学,黑龙江哈尔滨150040 [2]黑龙江中医药大学附属第一医院,黑龙江哈尔滨150040

出　　处：《四川中医》2024年第12期145-148,共4页Journal of Sichuan of Traditional Chinese Medicine

基　　金：黑龙江省省属本科高校中央支持地方高校改革发展资金(高水平人才项目)(编号:2021ZYGL001)。

摘　　要：盆腔炎性疾病(Pelvic inflammation disease,PID)是妇科临床常见病和多发病,如果治疗不当或病程迁延较久,则会发展成为盆腔炎性疾病后遗症(Sequelae of PID,SPID),盆腔炎性疾病后遗症可致不孕、输卵管妊娠和盆腔充血综合征等,严重影响妇女健康和生活质量。本文对黑龙江中医药大学附属第一医院门诊电子诊疗系统收集的以“活血化瘀法”治疗盆腔炎性疾病后遗症(Sequelae of pelvic inflammatory disease,SPID)的临床中药方剂进行收集整理和数据挖掘,得到核心药物及组方,为临床用药提供指导及参考。Pelvic inflammatory disease is a common and frequently occurring disease in gynecological clinic.If it is not properly treated or the course of disease lasts for a long time,it will develop into a sequela of pelvic inflammatory disease.The sequela of pelvic inflammatory disease can lead to infertility,tubal pregnancy and pelvic congestion syndrome,which seriously affects women's health and quality of life.This review collects and organizes clinical traditional Chinese medicine formulas for treating pelvic inflammatory disease sequelae(SPID)using the“activating blood circulation and resolving stasis method”collected by the outpatient electronic diagnosis and treatment system of the First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine,and conducts data mining to obtain core drugs and formulations,providing guidance and reference for clinical medication.

关 键 词：盆腔炎性疾病后遗症 活血化瘀法 数据挖掘 

分 类 号：R711.33[医药卫生—妇产科学]